HSBC maintains Buy on Zoetis, lowers price target to $95
HSBC analyst Rajesh Kumar has maintained a Buy rating on Zoetis (NYSE: ZTS) while lowering the price target to $95 from the previous $140. The revised target suggests a reassessment of the company's valuation or growth prospects, despite the continued positive stance on the stock.
*this image is generated using AI for illustrative purposes only.
HSBC analyst Rajesh Kumar has maintained a Buy rating on Zoetis (NYSE: ZTS) while lowering the price target to $95 from the previous $140. The revised target suggests a reassessment of the company's valuation or growth prospects, despite the continued positive stance on the stock.
Rating and Price Target Details
The decision to maintain a Buy rating indicates that the stock is expected to outperform the broader market. The reduction in the price target signals a more tempered outlook on the stock's near-term performance.
| Metric | Value |
|---|---|
| Rating | Buy |
| Previous Price Target | $140 |
| New Price Target | $95 |
Zoetis continues to be monitored for its operational performance and market conditions. The new price target provides a reference point for investors considering the stock's potential trajectory.
What specific factors led HSBC to lower the price target despite maintaining a Buy rating?
How might this revised price target impact investor sentiment toward Zoetis in the near term?
What operational or market conditions could drive Zoetis to outperform the new $95 target?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
